Arcellx (NASDAQ:ACLX – Get Free Report) and X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 63.2% of X4 Pharmaceuticals […]